XML 362 R16.htm IDEA: XBRL DOCUMENT v3.25.0.1
HSBC Holdings statement of cash flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from (used in) operating activities [abstract]      
Profit before tax $ 32,309 $ 30,348 $ 17,058
Adjustments for non-cash items:      
– depreciation, amortisation and impairment/expected credit losses 4,080 3,466 3,850
– share-based payment expense 529 482 400
– other non-cash items included in profit before tax (5,290) (4,299) (774)
Elimination of exchange differences [1] 26,734 (10,678) 48,718
Change in financial assets with HSBC undertakings designated and otherwise mandatorily measured at fair value (20,662) (9,994) 14,164
Change in net trading securities and derivatives (41,385) (63,247) 20,166
Change in other assets [2] 7,685 (10,254) (12,858)
Change in debt securities in issue 11,942 11,945 12,518
Change in financial liabilities designated at fair value (2,248) 10,097 (13,654)
Change in other liabilities (1,603) 8,742 6,021
Tax received (6,611) (4,117) (2,776)
Net cash from operating activities 65,305 39,111 19,355
Cash flows from (used in) investing activities [abstract]      
Purchase of financial investments [2] (523,454) (563,561) (511,097)
Proceeds from the sale and maturity of financial investments [2] 453,502 504,174 492,624
Net investment in intangible assets (2,542) (2,550) (3,125)
Net cash from investing activities (76,564) (62,912) (27,401)
Cash flows from (used in) financing activities [abstract]      
Issue of ordinary share capital and other equity instruments 3,602 1,996 0
Redemption of preference shares and other equity instruments (3,433) (4,003) (2,266)
Purchase of own shares (11,348) (5,812) (2,285)
Subordinated loan capital issued 4,361 5,237 7,300
Subordinated loan capital repaid [3] (2,000) (2,147) (1,777)
Net cash from financing activities (26,459) (17,558) (6,286)
Net decrease in cash and cash equivalents (37,718) (41,359) (14,332)
Cash and cash equivalents at 1 Jan 490,933 [4] 521,671 [4] 574,032
Exchange differences in respect of cash and cash equivalents (18,275) 10,621 (38,029)
Cash and cash equivalents at 31 Dec [4] 434,940 490,933 521,671
Cash and cash equivalents comprise:      
– cash collateral, net settlement accounts and items in course of collection from/transmission to other banks 9,827 14,866 18,878
– loans and advances to HSBC undertakings of one month or less 69,803 76,620 72,295
HSBC Holdings      
Cash flows from (used in) operating activities [abstract]      
Profit before tax 20,549 8,235 9,280
Adjustments for non-cash items:      
Adjustments for non-cash items 11,721 5,611 (2,500)
– depreciation, amortisation and impairment/expected credit losses 11,552 5,629 (2,428)
– share-based payment expense 1 0 1
– other non-cash items included in profit before tax 53 (38) (73)
Elimination of exchange differences [5] 115 20 0
Change in loans to HSBC undertakings (2,753) (1,267) (1,657)
Change in financial assets with HSBC undertakings designated and otherwise mandatorily measured at fair value (1,978) (7,767) (914)
Change in net trading securities and derivatives (1,537) (529) 4,712
Change in other assets 603 363 51
Change in financial investments 0 0 196
Change in debt securities in issue 469 1,964 (5,625)
Change in financial liabilities designated at fair value 292 3,096 (4,755)
Change in other liabilities (1,897) 1,947 (3,394)
Tax received 1,691 577 215
Net cash from operating activities 27,160 12,230 (4,391)
Cash flows from (used in) investing activities [abstract]      
Purchase of financial investments (29,812) (7,803) (21,481)
Proceeds from the sale and maturity of financial investments 31,779 20,074 17,165
Net cash outflow from acquisition of or increase in stake of subsidiaries (7,473) (2,517) (5,696)
Repayment of capital from subsidiaries 2,963 4,993 3,860
Net investment in intangible assets (43) (46) (39)
Net cash from investing activities (2,586) 14,701 (6,191)
Cash flows from (used in) financing activities [abstract]      
Issue of ordinary share capital and other equity instruments 3,648 2,059 67
Redemption of preference shares and other equity instruments (2,250) (4,003) (2,266)
Purchase of own shares (532) (855) (438)
Cancellation of shares (11,204) (5,812) (2,298)
Subordinated loan capital issued 4,268 5,270 7,300
Subordinated loan capital repaid (3,994) 0 0
Debt securities issued 16,102 17,180 18,076
Debt securities repaid (18,179) (13,047) (10,094)
Dividends paid on ordinary shares (15,348) (10,492) (5,330)
Dividends paid to holders of other equity instruments (1,062) (1,101) (1,214)
Net cash from financing activities (28,551) (10,801) 3,803
Net decrease in cash and cash equivalents (3,977) 16,130 (6,779)
Cash and cash equivalents at 1 Jan 22,814 6,756 13,535
Exchange differences in respect of cash and cash equivalents [6] (144) (72) 0
Cash and cash equivalents at 31 Dec 18,693 22,814 6,756
Cash and cash equivalents comprise:      
– cash at bank with HSBC undertakings 2,548 7,029 3,210
– cash collateral, net settlement accounts and items in course of collection from/transmission to other banks 2,544 3,422 3,544
– loans and advances to HSBC undertakings of one month or less 8,500 0 0
– treasury and other eligible bills $ 5,101 $ 12,363 $ 2
[1] Adjustment to bring changes between opening and closing balance sheet amounts to average rates. This is not done on a line-by-line basis, as details cannot be
determined without unreasonable expense.
[2] Post adoption of IFRS 17 ‘Insurance Contracts’, certain assets have been reclassified from ‘Investing activities’ to ‘Operating activities’. The comparative data
for 2022 have not been re-presented.
[3] Subordinated liabilities changes during the year are attributable to repayments of $(2.0)bn (2023: $(2.1)bn; 2022: $(1.8)bn) of securities. Non-cash changes
during the year included foreign exchange gains/losses of $1.6bn gain (2023: $0.6bn loss; 2022: $1.1bn gain) and fair value gains/losses of $1.0bn gain (2023:
$0.8bn loss; 2022: $3.1bn gain).
[4] At 31 December 2024, $50.4bn (2023: $61.8bn; 2022: $59.3bn) was not available for use by HSBC due to a range of restrictions, including currency exchange
and other restrictions.
[5] Adjustment to bring changes between opening and closing balance sheet amounts to average rates. This is not done on a line-by-line basis, as details cannot be
determined without unreasonable expense. As this change has immaterial impact, 2022 prior period comparatives have not been restated.
[6] In 2023, additional disclosure has been made in respect of exchange differences on cash and cash equivalents. As this change has immaterial impact, 2022 prior
period comparatives have not been restated.